IRIS
PETRILLO, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.706
AS - Asia 2.779
SA - Sud America 2.232
EU - Europa 854
AF - Africa 132
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 11.726
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.565
BR - Brasile 2.001
SG - Singapore 1.578
CN - Cina 399
HK - Hong Kong 314
IT - Italia 255
UA - Ucraina 162
DE - Germania 106
VN - Vietnam 86
AR - Argentina 82
TR - Turchia 68
MX - Messico 57
GB - Regno Unito 51
EC - Ecuador 49
RU - Federazione Russa 48
CA - Canada 45
BD - Bangladesh 39
UZ - Uzbekistan 39
ZA - Sudafrica 39
FR - Francia 36
FI - Finlandia 35
MA - Marocco 29
IN - India 26
IQ - Iraq 25
VE - Venezuela 25
JP - Giappone 24
CO - Colombia 21
PK - Pakistan 20
AZ - Azerbaigian 18
CL - Cile 18
NL - Olanda 18
PL - Polonia 17
AT - Austria 16
AE - Emirati Arabi Uniti 15
ES - Italia 15
KR - Corea 15
TN - Tunisia 15
KE - Kenya 14
SE - Svezia 14
AU - Australia 13
BE - Belgio 12
ID - Indonesia 12
JO - Giordania 12
KZ - Kazakistan 12
PE - Perù 12
EG - Egitto 10
NP - Nepal 10
OM - Oman 10
PY - Paraguay 10
UY - Uruguay 9
IE - Irlanda 8
IL - Israele 8
BY - Bielorussia 7
CR - Costa Rica 7
DO - Repubblica Dominicana 7
KW - Kuwait 7
LB - Libano 7
PS - Palestinian Territory 7
RO - Romania 7
AO - Angola 6
CH - Svizzera 6
CZ - Repubblica Ceca 6
PA - Panama 6
AL - Albania 5
DZ - Algeria 5
HN - Honduras 5
KG - Kirghizistan 5
NI - Nicaragua 5
BH - Bahrain 4
BN - Brunei Darussalam 4
GR - Grecia 4
JM - Giamaica 4
MD - Moldavia 4
RS - Serbia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
DK - Danimarca 3
LT - Lituania 3
SN - Senegal 3
XK - ???statistics.table.value.countryCode.XK??? 3
BG - Bulgaria 2
BO - Bolivia 2
CG - Congo 2
EU - Europa 2
GE - Georgia 2
GF - Guiana Francese 2
GT - Guatemala 2
IR - Iran 2
MK - Macedonia 2
MU - Mauritius 2
PH - Filippine 2
PR - Porto Rico 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
BW - Botswana 1
CY - Cipro 1
FK - Isole Falkland (Malvinas) 1
GA - Gabon 1
GN - Guinea 1
Totale 11.712
Salva come PNG Salva come JPEG
Città #
Dallas 2.743
Singapore 903
Chandler 831
Hong Kong 312
Princeton 240
Ashburn 157
Beijing 143
São Paulo 137
Wilmington 114
The Dalles 91
Columbus 84
Shanghai 84
Rio de Janeiro 67
New York 52
Belo Horizonte 50
Los Angeles 49
Santa Clara 44
San Jose 39
Tashkent 38
Ho Chi Minh City 37
Brasília 35
Sassari 33
Salvador 30
Council Bluffs 29
Falls Church 29
Campinas 28
Helsinki 26
Rome 26
Curitiba 24
Guarulhos 23
Porto Alegre 23
Tokyo 23
San Francisco 22
Munich 20
Norwalk 20
Toronto 18
Brooklyn 17
Johannesburg 17
Manaus 17
Sorocaba 17
Frankfurt am Main 16
Istanbul 16
Quito 16
Baku 15
Boardman 15
Ribeirão Preto 15
Seoul 15
Contagem 14
Nuremberg 14
Orem 14
Ankara 13
Ann Arbor 13
Campo Grande 13
Cape Town 13
Osasco 13
Praia Grande 13
Warsaw 13
Amman 12
Brussels 12
Falkenstein 12
Jacksonville 12
Mexico City 12
Nairobi 12
Recife 12
Atlanta 11
Düsseldorf 11
Goiânia 11
Montreal 11
Tianjin 11
Uberlândia 11
Denver 10
Guayaquil 10
Hanoi 10
Santo André 10
Baghdad 9
Bogotá 9
London 9
Montevideo 9
Rio Grande 9
Vila Velha 9
Volta Redonda 9
Boston 8
Buffalo 8
Caxias do Sul 8
Chicago 8
Cotia 8
Dhaka 8
Florianópolis 8
Foz do Iguaçu 8
Haikou 8
Houston 8
João Pessoa 8
Mauá 8
Muscat 8
Pelotas 8
Poplar 8
Ribeirão das Neves 8
São José dos Campos 8
Vienna 8
Vitória da Conquista 8
Totale 7.338
Salva come PNG Salva come JPEG
Nome #
Chemo-conization in Early-sTage cERvical caNcer >2 cm scheduled for fertilItY-sparing approach: an analysis of the ETERNITY project 300
Exploring Vascular Complications in Ovarian Cancer Surgery: A Narrative Literature Review with a New Management Proposal Algorithm 289
The role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer 275
Short- and long-term outcomes of vaginal, laparoscopic, and robotic-assisted surgery in “oldest old” endometrial cancer 261
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts 253
Primary extranodal vaginal non-hodgkin lymphoma: Diagnostic pitfalls and therapeutic challenges 162
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study 151
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study 136
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 127
Materno-Fetal and Neonatal Complications of Diabetes in Pregnancy: A Retrospective Study 127
A case of isolated ovarian recurrence from vulvar carcinoma 126
Colonic carcinoma metastatic to the endometrium: The importance of clinical history in averting misdiagnosis as a primary endometrial carcinoma 124
Efficacy and effectiveness of the bulking agents in the treatment of stress and mixed urinary incontinence: A systematic review and meta-analysis 122
Adjuvant HPV Vaccination to Prevent Recurrent Cervical Dysplasia after Surgical Treatment: A Meta-Analysis 122
A case of drug resistant clear cell ovarian cancer showing responsiveness to gemcitabine at first administration and at re-challenge 119
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study 119
ASO Author Reflections: Surgery and Bevacizumab in Ovarian Cancer 118
A complete pathological response to treatment in a young patient with locally advanced minimal deviationadenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 118
Assessing the long-term role of vaccination against hpv after loop electrosurgical excision procedure (Leep): A propensity-score matched comparison 117
Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients 117
Efficacy of HPV Vaccination in Women Receiving LEEP for Cervical Dysplasia: A Single Institution’s Experience 113
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 112
Comparison of perioperative outcomes between standard laparoscopic and robotic-assisted approach in patients with rectosigmoid endometriosis 112
Completion surgery after concomitant chemoradiation in obese women with locally advanced cervical cancer: Evaluation of toxicity and outcome measures 109
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 107
A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer 107
High Incidence of Gestational Trophoblastic Disease in a Third-Level University-Hospital, Italy: A Retrospective Cohort Study 106
Conservatively treated glassy cell carcinoma of the cervix 100
CD133 antigen expression in ovarian cancer 99
The impact of COVID-19 lockdown on admission to gynecological emergency department: results from a a multicenter italian study 99
Challenges in Gynecological Cancer: Biology, Diagnosis, Surgical, and Medical Treatment 99
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 96
Systematic Review of Cytoreductive Surgery and Bevacizumab-Containing Chemotherapy in Advanced Ovarian Cancer: Focus on Safety 94
Clinical impact on ovarian cancer patients of massive parallel sequencing for BRCA mutation detection: The experience at Gemelli hospital and a literature review 89
The relevance of prelamin A and RAD51 as molecular biomarkers in cervical cancer 89
Extended pharmacological thromboprophylaxis and clinically relevant venous thromboembolism after major abdominal and pelvic surgery: international, prospective, propensity score-weighted cohort study 86
Native tissue repair (NTR) versus transvaginal mesh interventions for the treatment of anterior vaginal prolapse: Systematic review and meta-analysis 86
Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study 85
Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer 85
Hospital costs incurred by the Italian National Health Service for invasive cervical cancer 84
The role of surgery in platinum-resistant ovarian cancer: A call to the scientific community 84
Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis 83
Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case-control study on survival in patients with two year follow-up 82
Fetal Growth and Neonatal Outcomes in Pregestational Diabetes Mellitus in a Population with a High Prevalence of Diabetes 82
Characteristics and outcomes of surgically staged multiple classifier endometrial cancer 80
Prognostic role and predictors of complete pathologic response to neoadjuvant chemotherapy in primary unresectable ovarian cancer 80
Preoperative serum human epididymis protein 4 levels in early stage endometrial cancer: A prospective study 80
Prognostic role of Ca125 response criteria and RECIST criteria: Analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer 80
Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: A case series 79
Recurrence in skeletal muscle from squamous cell carcinoma of the uterine cervix: A case report and review of the literature 78
Sox9 and Hif-2α regulate TUBB3 gene expression and affect ovarian cancer aggressiveness 78
Development of a Nomogram Predicting the Risk of Persistence/Recurrence of Cervical Dysplasia 78
Prevalence of HPV Infection and p16INK4a Overexpression in Surgically Treated Laryngeal Squamous Cell Carcinoma 77
Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy 76
Time trade-off procedure for measuring health utilities loss with human papillomavirus-induced diseases: A multicenter, retrospective, observational pilot study in Italy 76
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: Utility of a scoring system to predict outcomes 75
Vulvar squamous cell carcinoma with sarcoma-like stroma: A case report and review of the literature 73
Feasibility and safety of laparoscopic approach in obese patients with endometriosis: a multivariable regression analysis 73
Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: Long-term results 73
Timing and pattern of recurrence in ovarian cancer patients with high tumor dissemination treated with primary debulking surgery versus neoadjuvant chemotherapy 72
Self-reported long-term autonomic function after laparoscopic total mesometrial resection for early-stage cervical cancer: A multicentric study 72
Preoperative Anti-Class III β-Tubulin Antibodies As Relevant Clinical Biomarkers in Ovarian Cancer 72
HGF/c-Met axis drives cancer aggressiveness in the neo-adjuvant setting of ovarian cancer 72
Role of extracellular vesicles in epithelial ovarian cancer: A systematic review 72
Ovarian cancer patients with localized relapse: Clinical outcome and prognostic factors 72
Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B 71
Glassy cell carcinoma of the endometrium: A case report and review of the literature 71
Novel targets for VEGF-independent anti-angiogenic drugs 71
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study 70
Lidocaine spray vs mepivacaine local infiltration for suturing 1st/2nd grade perineal lacerations: a randomised controlled non-inferiority trial 69
Ovarian low and high grade serous carcinomas: Hidden divergent features in the tumor microenvironment 69
Targeting the hallmarks of ovarian cancer: The big picture 69
Polarisation of tumor-associated macrophages toward M2 phenotype correlates with poor response to chemoradiation and reduced survival in patients with locally advanced cervical cancer 69
Impact of postoperative cardiovascular complications on 30‐day mortality after major abdominal surgery: an international prospective cohort study 68
Laparoscopic Versus Laparotomic Surgical Staging for Early-Stage Ovarian Cancer: A Case-Control Study 68
Non-catalytic region of tyrosine kinase adaptor protein 2 (Nck2) pathways as factor promoting aggressiveness in ovarian cancer 68
Laparoscopic splenectomy both for primary cytoreductive surgery for advanced ovarian cancer and for secondary surgery for isolated spleen recurrence: feasibility and technique 68
Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience 68
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: A retrospective longitudinal analysis using matched tumor biopsies 66
Prognostic role of topoisomerase-IIα in advanced ovarian cancer patients 65
Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancer 65
Robotic Total Mesometrial Resection versus Laparoscopic Total Mesometrial Resection in Early Cervical Cancer: A Case-Control Study 65
Does the diagnosis center influence the prognosis of ovarian cancer patients submitted to neoadjuvant chemotherapy? 65
Tumor Size, an Additional Risk Factor of Local Recurrence in Low-Risk Endometrial Cancer: A Large Multicentric Retrospective Study 64
Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: A prospective study 64
Epithelial ovarian cancer relapsing as isolated lymph node disease: Natural history and clinical outcome 64
Expression and subcellular localization of CRH and its receptors in human endometrial cancer 63
Secondary cytoreduction in ovarian cancer: who really benefits? 63
Incidence and predictive factors for complications after uterine leiomyoma embolization 63
Sentinel Lymph Node Biopsy in Surgical Staging for High-Risk Groups of Endometrial Carcinoma Patients 63
Nek6 and Hif-1α cooperate with the cytoskeletal gateway of drug resistance to drive outcome in serous ovarian cancer 63
Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: A prospective, longitudinal study 61
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 61
Novel VEGF-independent strategies targeting tumor vasculature: Clinical aspects 60
Standardized training programmes for advanced laparoscopic gynaecological surgery 60
Laparoscopic radical hysterectomy in cervical cancer as total mesometrial resection (L-TMMR): A multicentric experience 60
Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study 60
Correlation of Leptin, Proinflammatory Cytokines and Oxidative Stress with Tumor Size and Disease Stage of Endometrioid (Type I) Endometrial Cancer and Review of the Underlying Mechanisms 60
Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: A retrospective study 60
Laparoscopic laterally extended endopelvic resection procedure for gynecological malignancies 60
Totale 9.433
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.166
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.166
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021301 0 0 0 0 0 0 5 0 152 122 15 7
2021/2022561 14 7 9 13 25 22 11 46 61 49 68 236
2022/20231.454 151 54 20 266 128 248 2 211 286 12 50 26
2023/2024332 81 31 17 11 23 15 15 35 0 3 27 74
2024/20254.406 59 33 250 123 211 174 307 950 1.522 496 175 106
2025/20264.826 226 1.300 1.835 579 652 234 0 0 0 0 0 0
Totale 11.950